Cargando…
Identification of novel bacterial DNA gyrase inhibitors: An in silico study
Owing to essential role in bacterial survival, DNA gyrase has been exploited as a validated drug target. However, rapidly emerging resistance to gyrase-targeted drugs such as widely utilized fluoroquinolones reveals the necessity to develop novel compounds with new mechanism of actions against this...
Autores principales: | Rahimi, Hamzeh, Najafi, Ali, Eslami, Habib, Negahdari, Babak, Moghaddam, Mehrdad Moosazadeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962306/ https://www.ncbi.nlm.nih.gov/pubmed/27499795 |
Ejemplares similares
-
An In-Silico Evaluation of Anthraquinones as Potential Inhibitors of DNA Gyrase B of Mycobacterium tuberculosis
por: Amorim, Juliana Carolina, et al.
Publicado: (2022) -
Discovery of Novel
Inhibitors of Bacterial DNA Gyrase
Using a QSAR-Based Approach
por: Jakhar, Ritu, et al.
Publicado: (2022) -
Selective DNA Gyrase Inhibitors: Multi-Target in Silico Profiling with 3D-Pharmacophores
por: Tomašič, Tihomir, et al.
Publicado: (2021) -
Novel Bacterial Topoisomerase Inhibitors Exploit Asp83 and the Intrinsic Flexibility of the DNA Gyrase Binding Site
por: Franco-Ulloa, Sebastian, et al.
Publicado: (2018) -
A contemporary review on the important role of in silico approaches for managing different aspects of COVID-19 crisis
por: Moradi, Mohammad, et al.
Publicado: (2022)